Browsing Tag
London Stock Exchange
142 posts
Aramco Q1 2026 profit jumps 26% to $33.6bn as East-West Pipeline absorbs Hormuz shock
Hormuz was closed for ten weeks. Aramco still beat consensus by $2.4bn, ramped its East-West Pipeline to max, and declared a $21.9bn dividend.
IAG (LSE: IAG) jumps 6.4% as British Airways owner moves to wipe out €825m of bond dilution
Three days after a profit warning, IAG is buying back €825m of 2028 convertibles. The move kills 5.6% dilution before it happens, and the market noticed.
Airtel Africa (LSE: AAF) jumps 14.5% as Bharti Airtel readies $3bn stake mop-up
Bharti Airtel wants more of Africa before Airtel Money lists. The 16% promoter stake mop-up could cost $3 billion and reset AAF's London share register.
Whitbread (LSE: WTB) bounces off post-results lows as Premier Inn value case attracts buyers
Whitbread fell 6 percent on FY26 results. A week later it leads the FTSE 100 risers. Premier Inn Germany just turned profitable for the first time.
BT Group (LSE: BT.A) shares hit multi-year high as JP Morgan flags dividend doubling
BT Group's altnet bear case is fading. JP Morgan thinks the dividend doubles by 2030. The 21 May results will decide if the rerating sticks.
Avacta Group (AIM: AVCT) preCISION data signals tumor selectivity index emerging as the new ADC battleground
Avacta is not just challenging Enhertu. It is rewriting the metric the entire ADC industry will be diligenced on. Tumor selectivity is the new battleground.
Man Group’s Abu Dhabi licence push strengthens ADGM’s claim in the global asset management race
Man Group wants a deeper Abu Dhabi base. ADGM’s asset management race is turning into a test of where global capital wants to sit next.
Defence Holdings (LSE: ALRT) silent for 11 weeks: Is Project Ixian close to a contract?
Defence Holdings PLC has not filed an RNS since 17 February 2026. Project Ixian, Gloucestershire Police and a new CEO sit behind the wall of silence.
Avacta Group (AIM: AVCT) delivers preCISION payload data that challenges Enhertu and Datroway tumor selectivity at Science Day 2026
Avacta is no longer pitching a platform. It is benchmarking preCISION directly against Enhertu and Datroway, and the tumor selectivity numbers matter.
Fermi Inc. faces board control fight as FRMI governance battle tests Project Matador strategy
Fermi has AI power ambition but boardroom chaos. Read how the FRMI fight could shape Project Matador and shareholder value.